NCT07684716 Individualized Non-pharmacological Intervention for Bowel Preparation
| NCT ID | NCT07684716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | General Hospital of Shenyang Military Region |
| Condition | Bowel Preparation for Colonoscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 339 participants |
| Start Date | 2026-06-08 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 339 participants in total. It began in 2026-06-08 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Colonoscopy is essential for the early detection of colorectal cancer. However, inadequate bowel preparation remains a common challenge, associated with reduced adenoma detection rates, prolonged procedure time, and increased healthcare costs. Current individualized regimens rely largely on higher laxative dosages-an approach with limited clinical utility. Non-pharmacological interventions, including dietary modification, physical activity, and health education, are safe and tend to have better patient adherence. The effectiveness of health education depends largely on message framing. Guided by information-framing theory, we developed an individualized non-pharmacological regimen. This randomized controlled trial aims to evaluate the efficacy of this regimen in improving bowel preparation quality.
Eligibility Criteria
Inclusion Criteria: * age ≥ 18 years; * outpatient scheduled for colonoscopy using oral laxatives for bowel preparation; * able to understand the study and provide written informed consent. Exclusion Criteria: * undergoing emergency colonoscopy; * suspected intestinal obstruction, stricture, or perforation; * severe cardiac, cerebral, hepatic, or renal disease; * severe psychiatric disorder; * impaired consciousness or communication difficulties; * pregnancy or lactation; * previous enrollment in this study.
Contact & Investigator
Xingshun Qi
STUDY CHAIR
The General Hospital of Northern Theater Command
Frequently Asked Questions
Who can join the NCT07684716 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bowel Preparation for Colonoscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07684716 currently recruiting?
Yes, NCT07684716 is actively recruiting participants. Contact the research team at xingshunqi@126.com for enrollment information.
Where is the NCT07684716 trial being conducted?
This trial is being conducted at Shenyang, China.
Who is sponsoring the NCT07684716 clinical trial?
NCT07684716 is sponsored by General Hospital of Shenyang Military Region. The principal investigator is Xingshun Qi at The General Hospital of Northern Theater Command. The trial plans to enroll 339 participants.